Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nucynta for severe chronic pain in knee osteoarthritis
NCT00982280Phase 3Terminated
- Sponsor
- Grünenthal GmbH
- Start
- Sep 2009
- Primary completion
- May 2010
- Countries
- 6
01
Overview
A Phase 3 trial of tapentadol in osteoarthritis (OA), chronic pain, sponsored by Grünenthal GmbH. Started Sep 2009; status: terminated.
02
Drugs
tapentadol
03
Conditions
osteoarthritis (OA)chronic pain
Beyond the preview
Go deeper on NCT00982280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00982280.